AU000000RMD6
AU000000RMD6
RESMED CDI 10:1 [RMD]
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 45.82B EUR | 4.1B EUR | 4.75B EUR | 5.24B EUR |
Enterprise Value | 18.16B EUR | 3.45B EUR | 3.93B EUR | 4.67B EUR |
Valuation Multiples | ||||
Trailing P/E | 21.16x | 2.69x | 3.12x | 4.67x |
Forward P/E | 16.93x | -- | -- | -- |
Price to Sales | 8.1x | 0.72x | 0.86x | 1.27x |
Price to Book | 2.04x | 0.62x | 0.73x | 0.83x |
EV/Revenue | 3.21x | 0.61x | 0.71x | 1.14x |
EV/EBITDA | 8.66x | 1.59x | 1.78x | 2.85x |
Price to FCF (P/FCF) | 48.78x | 2.52x | 2.73x | 4.29x |
EV/FCF | 19.33x | 2.12x | 2.26x | 3.82x |
FCF Yield | 2.05% | 39.74% | 36.57% | 23.34% |